Literature DB >> 17283097

Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin.

Miriam Schlee1, Jan Wehkamp, Artur Altenhoefer, Tobias A Oelschlaeger, Eduard F Stange, Klaus Fellermann.   

Abstract

Human beta-defensin 2 (hBD-2) is an inducible antimicrobial peptide synthesized by the epithelium to counteract bacterial adherence and invasion. Proinflammatory cytokines, as well as certain bacterial strains, have been identified as potent endogenous inducers. Recently, we have found that hBD-2 induction by probiotic Escherichia coli Nissle 1917 was mediated through NF-kappaB- and AP-1-dependent pathways. The aim of the present study was to identify the responsible bacterial factor. E. coli Nissle 1917 culture supernatant was found to be more potent than the pellet, indicating a soluble or shed factor. Chemical analysis demonstrated the factor to be heat resistant and proteinase digestible. Several E. coli Nissle 1917 deletion mutants were constructed and tested for their ability to induce hBD-2 expression in Caco-2 cells. Deletion mutants for flagellin specifically exhibited an impaired immunostimulatory capacity. Reinsertion of the flagellin gene restored the induction capacity to normal levels. Isolated flagellin from E. coli Nissle 1917 and from Salmonella enterica serovar Enteritidis induced hBD-2 mRNA significantly in contrast to the flagellin of the apathogenic E. coli strain ATCC 25922. H1 flagellin antiserum abrogated hBD-2 expression induced by flagellin as well as E. coli Nissle 1917 supernatant, confirming that flagellin is the major stimulatory factor of E. coli Nissle 1917.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17283097      PMCID: PMC1865783          DOI: 10.1128/IAI.01563-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

Review 1.  Pre-, pro- and synbiotics.

Authors:  S Bengmark
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2001-11       Impact factor: 4.294

2.  Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression.

Authors:  A T Gewirtz; T A Navas; S Lyons; P J Godowski; J L Madara
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

3.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

Authors:  P Gionchetti; F Rizzello; A Venturi; P Brigidi; D Matteuzzi; G Bazzocchi; G Poggioli; M Miglioli; M Campieri
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

4.  Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis.

Authors:  Daniel Rachmilewitz; Fanny Karmeli; Kenji Takabayashi; Tomoko Hayashi; Leonor Leider-Trejo; Jongdae Lee; Lorenzo M Leoni; Eyal Raz
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

5.  Probiotic bacteria enhance murine and human intestinal epithelial barrier function.

Authors:  K Madsen; A Cornish; P Soper; C McKaigney; H Jijon; C Yachimec; J Doyle; L Jewell; C De Simone
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

6.  Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: I kappa B alpha degradation, induction of nitric oxide synthase, induction of proinflammatory mediators, and cardiovascular dysfunction.

Authors:  T Eaves-Pyles; K Murthy; L Liaudet; L Virág; G Ross; F G Soriano; C Szabó; A L Salzman
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

7.  Salmonella enteritidis FliC (flagella filament protein) induces human beta-defensin-2 mRNA production by Caco-2 cells.

Authors:  K Ogushi ; A Wada; T Niidome; N Mori; K Oishi; T Nagatake; A Takahashi; H Asakura; S Makino ; H Hojo; Y Nakahara; M Ohsaki; T Hatakeyama; H Aoyagi; H Kurazono; J Moss; T Hirayama
Journal:  J Biol Chem       Date:  2001-05-31       Impact factor: 5.157

8.  Naip5 affects host susceptibility to the intracellular pathogen Legionella pneumophila.

Authors:  Edward K Wright; Sheryl A Goodart; Joseph D Growney; Vey Hadinoto; Matthew G Endrizzi; E Michelle Long; Keyvan Sadigh; Andrew L Abney; Isaac Bernstein-Hanley; William F Dietrich
Journal:  Curr Biol       Date:  2003-01-08       Impact factor: 10.834

9.  Flagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cells.

Authors:  Xin Zhou; Jorge A Girón; Alfredo G Torres; J Adam Crawford; Erasmo Negrete; Stefanie N Vogel; James B Kaper
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea.

Authors:  Vibeke Rosenfeldt; Kim Fleischer Michaelsen; Mogens Jakobsen; Charlotte Nexmann Larsen; Peter Lange Møller; Pernille Pedersen; Michael Tvede; Heike Weyrehter; Niels Henrik Valerius; Anders Paerregaard
Journal:  Pediatr Infect Dis J       Date:  2002-05       Impact factor: 2.129

View more
  102 in total

Review 1.  Innate immune signaling in defense against intestinal microbes.

Authors:  Melissa A Kinnebrew; Eric G Pamer
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 2.  Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa.

Authors:  Peter A Bron; Peter van Baarlen; Michiel Kleerebezem
Journal:  Nat Rev Microbiol       Date:  2011-11-21       Impact factor: 60.633

Review 3.  Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics.

Authors:  Michele Caselli; Giuseppina Vaira; Girolamo Calo; Francesco Papini; John Holton; Dino Vaira
Journal:  Adv Nutr       Date:  2011-09-06       Impact factor: 8.701

Review 4.  Modulating immunity as a therapy for bacterial infections.

Authors:  Robert E W Hancock; Anastasia Nijnik; Dana J Philpott
Journal:  Nat Rev Microbiol       Date:  2012-03-16       Impact factor: 60.633

Review 5.  Probiotics, enteric and diarrheal diseases, and global health.

Authors:  Geoffrey A Preidis; Colin Hill; Richard L Guerrant; B S Ramakrishna; Gerald W Tannock; James Versalovic
Journal:  Gastroenterology       Date:  2010-11-12       Impact factor: 22.682

Review 6.  Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV.

Authors:  Ava Behrouzi; Hoora Mazaheri; Sarvenaz Falsafi; Zahra Hoseini Tavassol; Arfa Moshiri; Seyed Davar Siadat
Journal:  J Diabetes Metab Disord       Date:  2020-05-01

7.  Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science.

Authors:  Elaine O Petrof
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-09-01

8.  A question of survival? Interaction between probiotics and the gastrointestinal tract.

Authors:  Herbert Lochs
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

9.  Differential induction of antimicrobial REGIII by the intestinal microbiota and Bifidobacterium breve NCC2950.

Authors:  Jane M M Natividad; Christina L Hayes; Jean-Paul Motta; Jennifer Jury; Heather J Galipeau; Vivek Philip; Clara L Garcia-Rodenas; Hiroshi Kiyama; Premysl Bercik; Elena F Verdu
Journal:  Appl Environ Microbiol       Date:  2013-10-04       Impact factor: 4.792

Review 10.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.